Thrombi Clinical Trials

8 recruitingLast updated: June 18, 2026

There are 8 actively recruiting thrombi clinical trials across 19 countries. Studies span Phase 3, Not Applicable, Phase 1, Phase 4. Top locations include London, United Kingdom, Vienna, Austria, Durham, North Carolina, United States. Updated daily from ClinicalTrials.gov.


Thrombi Trials at a Glance

8 actively recruiting trials for thrombi are listed on ClinicalTrialsFinder across 6 cities in 19 countries. The largest study group is Phase 3 with 2 trials, with the heaviest enrollment activity in London, Vienna, and Durham. Lead sponsors running thrombi studies include Octapharma, Frankston Hospital, and City Therapeutics.

Browse thrombi trials by phase

About Thrombi Clinical Trials

Looking for clinical trials for Thrombi? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Thrombi trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Thrombi clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 3

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

Congenital Antithrombin Deficiency
Octapharma38 enrolled30 locationsNCT04918173
Recruiting

Engagement Study for Participants With Factor V Leiden and Prothrombin G20210A Mutations

Factor V LeidenProthrombin G20210A
Richmond Research Institute100 enrolled1 locationNCT07584265
Recruiting
Phase 3

Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass

Acquired Antithrombin Deficiency
Octapharma120 enrolled27 locationsNCT06096116
Recruiting
Phase 1

A Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CITY-FXI in Healthy Adults and Adults With FV Leiden or Prothrombin G20210A Mutation

Factor V LeidenProthrombin G20210A
City Therapeutics128 enrolled1 locationNCT07430397
Recruiting

Evaluation of the Relevance of Antithrombin Prescriptions at Strasbourg University Hospitals

Antithrombinemia
University Hospital, Strasbourg, France160 enrolled1 locationNCT07276074
Recruiting

Effects of Bothrops Spp. Snake Envenomation on Willebrand Factor Activity in Martinique and French Guiana

coagulopathyThrombiHemorrhage+1 more
University Hospital Center of Martinique30 enrolled1 locationNCT06304714
Recruiting
Not Applicable

Effects of a Manual Therapy Program to Reduce the Evolution Time of Axillary Web Syndrome

Breast CancerMastectomy; LymphedemaThrombi+3 more
University of Malaga46 enrolled1 locationNCT05115799
Recruiting
Phase 4

A open label, phase IV clinical trial examining the efficacy of Prothrombinex alone verses Prothrombinex combined with fresh frozen plasma in patients who require Warfarin reversal.

The efficacy to reverse the effect of warfarin by prothrombinex alone
Frankston Hospital40 enrolled1 locationACTRN12607000567426